Page 30 - Gastrointestinal Bleeding (Xuất huyết tiêu hóa)
P. 30

304     PART III  Symptoms, Signs, and Biopsychosocial Issues


         The colonoscopic appearance of the mucosa includes erythema,
         friability,  and  exudate.  Mucosal  biopsy  specimens  may  suggest
         ischemic changes but are generally used to exclude infectious
         or Crohn colitis. Ischemic colitis usually resolves in a few days
         and generally does not require colonoscopic hemostasis or anti-
         biotic therapy. In the UCLA CURE experience, approximately
         10% of patients with ischemic colitis and severe hematochezia
         had a focal ulcer with a major stigma of hemorrhage on urgent
         colonoscopy. 288  After detection of arterial blood flow with DEP,
         the recommended treatment in these cases is epinephrine injec-
         tion and hemoclipping, similar to that for other ulcers. In a large
         retrospective series from Kaiser, no episodes of rebleeding from
         ischemic colitis occurred over a 4-year follow-up period. 235  On
         the other hand, patients with large-vessel mesenteric ischemia
         usually have worse outcomes, including higher rates of rebleed-
         ing, perforation, surgery, and death.
            IBD that involves the colon can rarely cause severe acute LGI
         bleeding (see Chapter 115). In a case series from the Mayo Clinic,
         most of these patients had Crohn disease, and most were successfully   Fig. 20.20  Endoscopic appearance of postpolypectomy bleeding in
         treated medically. 289  Three of the 31 patients in this series under-  the colon. Bleeding occurred 7 days after snare polypectomy of a large
         went endoscopic therapy with epinephrine injection alone or with   pedunculated polyp. Note the nonbleeding visible vessel (arrow) in the
         MPEC for an adherent clot or an oozing ulcer. These 3 patients had   ulcerated polypectomy site.
         no rebleeding, but 23% of the other 28 patients had rebleeding at a
         median of 3 days (range, 1 to 75 days) after the initial bleed; 39% of
         the patients with severe bleeding eventually required surgery.  lesion to slow active bleeding, and hemoclips can be applied to
            Infectious colitis should be excluded in any patient with severe   treat SRH on ulcerated lesions that cannot be resected endoscop-
         LGI bleeding and colitis (see Chapters 110 and 112). LGI bleed-  ically. Hemostatic powder may have a palliative role in reducing
                                                                                                         43
         ing can occur with infection caused by Campylobacter jejuni, Sal-  acute bleeding, prior to definitive treatment (see earlier). When
         monella, Shigella, enterohemorrhagic Escherichia coli (O157:H7),   possible, colon polyps can be removed to stop bleeding. Surgical
         CMV, or Clostridiodes difficile. Significant blood loss is rare except   resection is usually required to prevent rebleeding from a large,
         in patients with severe coagulopathy. The diagnosis is made by   ulcerated sessile lesion (see Chapters 126 and 127); however,
         stool cultures and flexible sigmoidoscopy or colonoscopy. Treat-  most patients with colon polyps or cancer and severe hemato-
         ment is with medical management; the use of antibiotics depends   chezia have advanced stage disease and high early mortality and
         on the causative organism. Endoscopic management generally   should be considered for nonsurgical therapies. 296  
         has no role in infectious colitis. 
                                                              Radiation Proctitis
         Postpolypectomy Bleeding
                                                              Radiation proctitis usually causes mild chronic hematochezia but
         Painless bleeding occurs after approximately 1% of colonoscopic   occasionally can cause acute severe LGI bleeding. Ionizing radiation
         polypectomies. It is most common 5 to 7 days after polypec-  can cause acute and chronic damage to the normal colon and rectum
         tomy but can occur from 1 to 14 days after the procedure. It is   when used to treat pelvic tumors—gynecologic, prostatic, bladder,
         generally self-limited and mild to moderate, with 50% to 75%   or rectal (see Chapter 41). Acute self-limited diarrhea, tenesmus,
         of patients requiring blood transfusions. 290-293  Reported risk fac-  abdominal cramping, and, rarely, bleeding develops for a few weeks
         tors for postpolypectomy bleeding include a large polyp size (>2   in approximately 75% of patients who have received a radiation
         cm), thick stalk, sessile type, location in the right colon, use of   dose of 4000 cGy. Chronic radiation effects occur 6 to 18 months
         anticoagulants, and use of aspirin or another NSAID. During   after completion of treatment and manifest as bright red blood with
         urgent colonoscopy of patients with severe delayed postpolyp-  bowel movements. Bowel injury resulting from chronic radiation
         ectomy bleeding, an ulceration with a major stigma of hemor-  is related to vascular damage, with subsequent mucosal ischemia,
         rhage is usually found at the site of the polypectomy (Fig. 20.20).   thickening, and ulceration. Much of this damage is thought to result
         In patients with severe bleeding in whom a SRH is found in the   from chronic hypoxic ischemia and oxidative stress.
         ulceration, 294,295  a DEP can be used to detect underlying arterial   Flexible sigmoidoscopy or colonoscopy reveals telangiectasias,
         blood flow and the need for endoscopic hemostasis. Endoscopic   friability, and sometimes ulceration in the rectum (Fig. 20.21).
         management techniques for delayed postpolypectomy bleeding   Oozing bleeding is common, and often other nonbleeding rectal
         depend on the stigma found and are similar to those used for pep-  telangiectasias are seen. Internal hemorrhoids are often seen as
         tic ulcer hemorrhage, including epinephrine injection, thermal   well and are frequently misdiagnosed as the cause of the rectal
         coagulation, hemoclip placement, and combination therapy. Most   bleeding by those unfamiliar with radiation telangiectasias.
         major SRH in postpolypectomy ulcers are treated with hemoclip-  Treatment initially focuses on avoidance of aspirin and other
         ping (with or without epinephrine injection) because hemoclips   NSAIDs, consumption of a high-fiber diet, and iron supplemen-
         do not cause tissue damage, as is seen with thermal coagulation.   tation if the patient is anemic. Medical therapy with topical or
                                                              oral  5-aminosalicylic  acid  (mesalamine),  sucralfate,  or  gluco-
         Colon Neoplasia                                      corticoids may be prescribed but are not generally effective. 297
                                                              Thermal therapy is usually successful, but repeated treatments
         Patients with colon polyps and cancer can present with acute   with MPEC or argon plasma coagulation are necessary to achieve
         hematochezia. Often, these patients have a microcytic iron defi-  good outcomes. 289  Topical formalin applied directly to the rec-
         ciency anemia consistent with slow GI blood loss (see later) before   tal mucosa can reduce bleeding, 299  as can the use of hyperbaric
         more overt bleeding occurs.  Colonic neoplasia  was the eighth   oxygen. 300  Antioxidant vitamins, such as vitamins E and C, have
         most common cause of severe hematochezia in a large CURE   also been reported to decrease bleeding from chronic radiation
         series. 296  At colonoscopy, epinephrine can be injected into the   proctitis (see Chapter 41). 301  
   25   26   27   28   29   30   31   32   33   34   35